Antitumor agent-115 is a potent in vitro antitumor compound that inhibits the proliferation of murine breast cancer 4T1 cells (IC50: 0.34–24.14 μM); it arrests the cell cycle, reduces mitochondrial membrane potential, and induces apoptosis in 4T1 cells (IC50 for cell viability: 8–25 μmol/L), and is used in breast cancer research.